Raffles Medical Group Ltd

SGX:BSL.SI

0.89 (SGD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SGD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Revenue 708.032766.537723.791568.203522.038489.135477.583473.608410.535374.641340.989311.633272.783239.123218.61200.769168.659134.248112.898101.45699.10587.99776.304
Cost of Revenue 392.097126.556143.27135.775110.96999.51893.62691.6581.14174.19762.86261.12251.48544.10540.54935.53819.37216.57913.7111.94312.1359.0598.789
Gross Profit 315.935639.981580.521432.428411.069389.617383.957381.958329.394300.444278.127250.511221.298195.018178.061165.231149.287117.66999.18889.51386.9778.93867.515
Gross Profit Ratio 0.4460.8350.8020.7610.7870.7970.8040.8060.8020.8020.8160.8040.8110.8160.8150.8230.8850.8770.8790.8820.8780.8970.885
Reseach & Development Expenses 00000000000000000000000
General & Administrative Expenses 000000000000000085.93969.28461.52356.68856.7485045.02
Selling & Marketing Expenses 00000000000000000000000
SG&A 142.43849.64141.64838.74441.15646.70444.82546.98635.7749.8978.550000085.93969.28461.52356.68856.7485045.02
Other Expenses 57.7421.4150.9012.8730.9282.5450.7480000000000000000
Operating Expenses 200.18425.816457.72342.07332.816305.382303.871300.012248.79220.117183.8184.156161.788142.049132.604126.258121.071100.32686.62678.6177.39972.96167.289
Operating Income 115.755195.846121.30688.44276.16884.23580.08681.94680.60480.32794.32766.35559.5152.96945.45738.97328.21619.2112.56211.8939.8796.2751.181
Operating Income Ratio 0.1630.2550.1680.1560.1460.1720.1680.1730.1960.2140.2770.2130.2180.2220.2080.1940.1670.1430.1110.1170.10.0710.015
Total Other Income Expenses Net 3.684-4.142-5.722-4.003-0.244-0.1010.7320.9841.0030.9540.9110.23-0.070.127-0.41-0.62313.2060.8342.2341.1180.329-0.173-8.366
Income Before Tax 119.439191.704115.58484.43975.92484.13480.81882.9381.60781.28195.23866.58559.4453.09645.04738.3541.42220.04414.79613.01110.2086.102-7.185
Income Before Tax Ratio 0.1690.250.160.1490.1450.1720.1690.1750.1990.2170.2790.2140.2180.2220.2060.1910.2460.1490.1310.1280.1030.069-0.094
Income Tax Expense 28.34948.00231.86819.76915.40213.33112.15714.98412.57613.3199.9439.3768.8197.6147.0146.695.4984.2772.7582.9572.21.5960.323
Net Income 90.15143.21484.17165.89160.27371.05670.77970.2169.29167.63984.89256.84950.39645.26537.88231.54735.86315.71311.9589.4818.064.506-7.508
Net Income Ratio 0.1270.1870.1160.1160.1150.1450.1480.1480.1690.1810.2490.1820.1850.1890.1730.1570.2130.1170.1060.0930.0810.051-0.098
EPS 0.0490.0770.0450.0360.0330.040.040.040.0410.040.0510.0350.0320.0290.0240.020.0250.0120.010.0080.0070.004-0.007
EPS Diluted 0.0480.0770.0450.0360.0330.040.040.040.040.040.0510.0350.0310.0280.0240.020.0240.0120.010.0080.0070.004-0.007
EBITDA 132.89257.121162.761127.003109.21103.59196.01497.74994.50990.985103.55574.72366.93260.32152.445.64332.43620.76815.66713.94812.919.3552.754
EBITDA Ratio 0.1880.3350.2250.2240.2090.2120.2010.2060.230.2430.3040.240.2450.2520.240.2270.1920.1550.1390.1370.130.1060.036